CreditReports.dk
HomeScreen companies

Valeos Pharma A/S Financials, key figures and credit report

CVR number: 39696614 Established 2018 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Østervej 2, 4960 Holeby tel: 20651018
Gross profit 975.9 kDKK FY 2025 +125.4% vs 2024
EBIT -13 741.4 kDKK FY 2025 +21.6% vs 2024
Net debt 50 604.9 kDKK FY 2025 +10.3% vs 2024
Quick ratio 0.2 FY 2025 -0.2 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit-3 377.00-5 901.90-5 838.51-3 846.79975.95
Employee benefit expenses-4 015.00-9 038.53-9 038.53-10 558.63-11 603.89
Total depreciation-20.00-2 354.40-2 354.40-3 113.59-3 113.42
EBIT-7 412.00-17 294.83-17 231.43-17 519.01-13 741.36
Other financial income0.61
Other financial expenses- 797.00-3 873.17-3 936.56-4 181.99-3 411.18
Pre-tax profit-8 209.00-21 168.00-21 168.00-21 701.00-17 151.94
Income taxes1 801.004 634.014 634.014 756.293 664.57
Net earnings-6 408.00-16 533.98-16 533.98-16 944.71-13 487.36

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Buildings1.0049 200.1049 200.1046 215.0843 184.52
Machinery and equipment161.00259.07259.07176.2193.34
Advance payments and construction in progress40 307.00
Tangible assets total40 469.0049 459.1649 459.1646 391.2943 277.87
Investments total431.41433.58449.10
Non-current other receivables333.00431.41
Long term receivables total333.00431.41
Semifinished products463.34463.341 152.95769.72
Raw materials and consumables112.15140.23
Finished products/goods1 021.501 021.501 457.841 913.14
Inventories total1 484.841 484.842 722.952 823.10
Current trade debtors248.5661.17
Prepayments and accrued income160.00451.95451.95755.53456.39
Current other receivables1 815.001 866.201 866.201 382.491 088.56
Current deferred tax assets1 807.007 401.547 401.546 209.254 681.81
Short term receivables total3 782.009 719.699 719.698 595.836 287.94
Cash and bank deposits5 359.00
Cash and cash equivalents5 359.00
Balance sheet total (assets)49 943.0061 095.1061 095.1058 143.6452 838.01

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital515.00526.69526.69802.63802.63
Share premium account140.00140.00140.00140.00140.00
Retained earnings22 285.007 439.257 439.2522 802.275 857.56
Profit of the financial year-6 408.00-16 533.98-16 533.98-16 944.71-13 487.36
Shareholders equity total16 532.00-8 428.04-8 428.046 800.20-6 687.17
Provisions6.001 153.722 322.25
Capital loans22 729.0026 566.6426 566.6424 980.8523 460.00
Non-current loans from credit institutions8 232.0016 366.5719 786.591 897.024 986.39
Non-current other liabilities147.003 576.97156.952 793.611 820.66
Non-current liabilities total31 108.0046 510.1946 510.1929 671.4830 267.05
Current loans from credit institutions17 650.5817 650.5818 771.6419 501.94
Current trade creditors1 583.004 529.714 529.701 093.584 235.79
Current owed to participating208.00216.49216.49220.82225.23
Current owed to group member2 431.39
Other non-interest bearing current liabilities506.00616.18616.19432.21541.53
Current liabilities total2 297.0023 012.9523 012.9520 518.2426 935.87
Balance sheet total (liabilities)49 943.0061 095.1061 095.1058 143.6452 838.01
Page generated